Document Detail


Approaches for targeting blood pressure control in sleep disorders.
MedLine Citation:
PMID:  22820373     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE OF REVIEW: One of the underappreciated causes of hypertension is disordered sleep. There have been a number of studies evaluating sleep in the context of blood pressure control, and these will be reviewed.
RECENT FINDINGS: Original novel articles document that disruption of deep sleep stage, regardless of cause, if chronic, contributes to an increased risk for development of hypertension. Studies have evaluated disrupted sleep especially in older people requiring use of the bathroom at night and demonstrate higher risk of hypertension in such people. Correction of sleep apnea with continuous positive airway pressure (CPAP) reduces blood pressure in those who are adherent; however, as the reduction is only from 2 to 5 mmHg systolic, adjunctive medications are almost always needed. Use of angiotensin receptor blockers and some β-blockers has shown some improvement in blood pressure. Renal denervation has also been shown in a pilot study to offer benefit on blood pressure reduction.
SUMMARY: Innovations of combined use of devices with certain classes of antihypertensive medications help reduce blood pressure in people with sleep disorders. CPAP alone provides only modest reduction in blood pressure; however, restoration of deep sleep reduces blood pressure and reduces variability.
Authors:
Amy Guralnick; George L Bakris
Related Documents :
10653373 - Cardioprotective effect of diadenosine tetraphosphate (ap4a) preservation in hypothermi...
1291083 - Effects of potassium channel modulation during global ischaemia in isolated rat heart w...
16061043 - Can we justify goal blood pressure of <140/90 mm hg in most hypertensives?
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current opinion in nephrology and hypertension     Volume:  21     ISSN:  1473-6543     ISO Abbreviation:  Curr. Opin. Nephrol. Hypertens.     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-08-09     Completed Date:  2013-01-03     Revised Date:  2013-05-02    
Medline Journal Info:
Nlm Unique ID:  9303753     Medline TA:  Curr Opin Nephrol Hypertens     Country:  England    
Other Details:
Languages:  eng     Pagination:  469-74     Citation Subset:  IM    
Affiliation:
Department of Medicine, Section of Pulmonary and Critical Care Medicine, The University of Chicago Medicine, Chicago, Illinois 60637, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antihypertensive Agents / therapeutic use*
Blood Pressure / physiology*
Continuous Positive Airway Pressure / adverse effects
Humans
Hypertension / drug therapy*,  etiology,  physiopathology
Sleep Disorders / complications*,  drug therapy,  physiopathology
Treatment Outcome
Chemical
Reg. No./Substance:
0/Antihypertensive Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Renin and prorenin as biomarkers in hypertension.
Next Document:  Modulation of glutamine metabolism by the PI(3)K-PKB-FOXO network regulates autophagy.